Experimental hemosiderosis: relationship between skin pigmentation and hemosiderin

Area of Science:

• Dermatology
• Histology
• Medical Biochemistry

Background:

• Hemochromatosis is a disorder associated with iron overload.
• Skin hyperpigmentation is a common clinical manifestation of hemochromatosis.
• The precise mechanisms linking iron deposition to skin pigmentation changes require further elucidation.

Purpose of the Study:

• To investigate the relationship between iron deposition, hemosiderin accumulation, and skin pigmentation.
• To determine the cellular localization of hemosiderin in the skin.
• To explore the potential role of hemosiderin in facial hyperpigmentation observed in hemochromatosis.

Main Methods:

• Hairless mice received controlled doses of iron via injection.
• Skin color changes were monitored over an 8-month period post-injection.
• Histological examination identified hemosiderin granule deposition and cellular localization within the skin.

Main Results:

• Maximum skin darkening occurred 24–48 hours after the final iron injection, fading over 8 months.
• Hemosiderin granules were found extracellularly and within dermal macrophages, epidermal Langerhans cells, and indeterminate dendritic cells.
• Facial skin exhibited greater iron deposition and darker pigmentation compared to dorsal skin.

Conclusions:

• Skin discoloration in hemochromatosis may be partly due to hemosiderin accumulation.
• Increased hemosiderin content in facial skin could enhance melanocyte activation, leading to pronounced facial hyperpigmentation.
• Hemosiderin deposition is a key factor in iron-induced skin pigmentation changes.